21 CFR 500.88
§ 500.88 Regulatory method.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 500.88, § 500.88 Regulatory method, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/86805
- Permanent ID
ys:prov:86805@1- SHA-256
fd5e8abee83380723f993c6fbbf13fd028080d1d9935b7929374663d8edd1f45
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) The sponsor shall submit for evaluation and validation a regulatory method developed to monitor compliance with FDA's operational definition of no residue.
(b) The regulatory method must be able to confirm the identity of the marker residue in the target tissue at a minimum concentration corresponding to the Rm. FDA will determine the LOD from the submitted analytical method validation data.
(c) FDA will publish in the Federal Register the complete regulatory method for ascertaining the marker residue in the target tissue in accordance with the provisions of sections 409(c)(3)(A), 512(d)(1)(I), and 721(b)(5)(B) of the act.
(d) If the sponsor initially submitted a request for an import tolerance under § 510.205 of this chapter, FDA will make the complete regulatory method for ascertaining the marker residue in the target tissue publicly available pursuant to § 510.207(b) of this chapter.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.